Yoon-Hee Cheon
Overview
Explore the profile of Yoon-Hee Cheon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheon Y, Lee C, Chung C, Kim J, Lee M
Nutrients
. 2024 Aug;
16(16).
PMID: 39203823
Sarcopenia, a condition caused by an imbalance between muscle growth and loss, can severely affect the quality of life of elderly patients with metabolic, inflammatory, and cancer diseases. Vigeo, a...
2.
Eun S, Chung C, Cheon Y, Park G, Lee C, Kim J, et al.
Mol Med Rep
. 2024 May;
30(1).
PMID: 38785149
Promotion of myoblast differentiation by activating mitochondrial biogenesis and protein synthesis signaling pathways provides a potential alternative strategy to balance energy and overcome muscle loss and muscle disorders. (Lour.) Baill....
3.
Cheon Y, Lee C, Eun S, Park G, Chung C, Kim J, et al.
Exp Ther Med
. 2024 Apr;
27(5):208.
PMID: 38590570
Rheumatoid arthritis (RA) is an autoimmune and chronic inflammatory disease characterized by articular cartilage destruction, bone destruction and synovial hyperplasia. It has been suggested that Vigeo, a mixture of ,...
4.
Eun S, Park G, Cheon Y, Lee M, Cho H, Kim J
J Cell Biochem
. 2024 Jan;
125(2):e30518.
PMID: 38224182
Excessive bone-resorbing osteoclast activity during bone remodeling is a major feature of bone diseases, such as osteoporosis. Therefore, the inhibition of osteoclast formation and bone resorption can be an effective...
5.
Kim J, Cheon Y, Ahn S, Kwak S, Chung C, Lee C, et al.
BMC Complement Med Ther
. 2022 Aug;
22(1):214.
PMID: 35948905
Background: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that causes local bone erosion and systemic osteoporosis. Harpagoside (HAR), an iridoid glycoside, has various pharmacological effects on pain, arthritis,...
6.
Eun S, Cheon Y, Park G, Chung C, Lee C, Kim J, et al.
Nutrients
. 2021 Nov;
13(11).
PMID: 34836159
Vigeo is a mixture of fermented extracts of Maxim (ESM), (Miq.) Nakai (AJN), and Koidzumi (AJK) manufactured using the traditional Korean nuruk fermentation method. Although the bioactive effects of ESM,...
7.
Cheon Y, Lee C, Kim S, Park G, Kwak S, Cho H, et al.
Biomed Pharmacother
. 2021 Jul;
139:111697.
PMID: 34243614
Excessive osteoclast activity, along with relatively weak osteoblast function, is strongly associated with bone disease. Therefore, studies to identify novel anti-osteoporosis candidates with dual actions of inhibiting osteoclastogenesis and increasing...
8.
Park G, Cheon Y, Eun S, Lee C, Lee M, Kim J, et al.
Molecules
. 2021 Jun;
26(9).
PMID: 34062884
Osteoporosis is a systemic metabolic bone disorder that is caused by an imbalance in the functions of osteoclasts and osteoblasts and is characterized by excessive bone resorption by osteoclasts. Targeting...
9.
Kwak S, Cheon Y, Lee C, Jun H, Yoon K, Lee M, et al.
Nutrients
. 2020 Oct;
12(10).
PMID: 33081167
Dietary procyanidin has been shown to be an important bioactive component that regulates various pharmacological activities to maintain metabolic homeostasis. In particular, grape seed proanthocyanidin extract (GSPE) is a commercially...
10.
Cheon Y, Lee C, Jeong D, Kwak S, Kim S, Lee M, et al.
Int J Mol Sci
. 2020 Sep;
21(17).
PMID: 32899248
Receptor activator of NF-κB ligand (RANKL) induces generation of intracellular reactive oxygen species (ROS), which act as second messengers in RANKL-mediated osteoclastogenesis. Dual oxidase maturation factor 1 (Duoxa1) has been...